Line 416: |
Line 416: |
| |Acute myeloid leukaemia with minimal differentiation | | |Acute myeloid leukaemia with minimal differentiation |
| |Disease | | |Disease |
− | |Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | + | | |
| | | | | |
| | | | | |
Line 432: |
Line 432: |
| |Acute myeloid leukaemia without maturation | | |Acute myeloid leukaemia without maturation |
| |Disease | | |Disease |
− | |Jennelle C. Hodge, PhD, FACMG | + | | |
| | | | | |
| | | | | |
Line 448: |
Line 448: |
| |Acute myeloid leukaemia with maturation | | |Acute myeloid leukaemia with maturation |
| |Disease | | |Disease |
− | |Jennelle C. Hodge, PhD, FACMG | + | | |
| | | | | |
| | | | | |
Line 464: |
Line 464: |
| |Acute basophilic leukaemia | | |Acute basophilic leukaemia |
| |Disease | | |Disease |
− | |Ashwini Yenamandra PhD FACMG | + | | |
| | | | | |
| | | | | |
Line 472: |
Line 472: |
| | | | | |
| | | | | |
− | | | + | |Acute Basophilic Leukemia |
− | | | + | |Ashwini Yenamandra PhD FACMG |
− | | | + | |Complete |
| | | | | |
| | | | | |
Line 480: |
Line 480: |
| |Acute myelomonocytic leukaemia | | |Acute myelomonocytic leukaemia |
| |Disease | | |Disease |
− | |Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR | + | | |
| | | | | |
| | | | | |
Line 488: |
Line 488: |
| | | | | |
| | | | | |
− | | | + | |Acute Myelomonocytic Leukemia |
− | | | + | |Fei Yang, MD, FACMG <br> Oregon Health & Science University |
− | | | + | |Complete |
| | | | | |
| | | | | |
Line 496: |
Line 496: |
| |Acute monocytic leukaemia | | |Acute monocytic leukaemia |
| |Disease | | |Disease |
− | |Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR | + | | |
| | | | | |
| | | | | |
Line 504: |
Line 504: |
| | | | | |
| | | | | |
− | | | + | |Acute Monoblastic and Monocytic Leukemia |
− | | | + | |Fei Yang, MD, FACMG <br> Oregon Health & Science University |
− | | | + | |Complete |
| | | | | |
| | | | | |
Line 512: |
Line 512: |
| |Acute erythroid leukaemia | | |Acute erythroid leukaemia |
| |Disease | | |Disease |
− | |Ashwini Yenamandra PhD FACMG | + | | |
| | | | | |
| | | | | |
Line 520: |
Line 520: |
| | | | | |
| | | | | |
− | | | + | |Pure Erythroid Leukemia |
− | | | + | |Ashwini Yenamandra PhD FACMG |
− | | | + | |Complete |
| | | | | |
| | | | | |
Line 528: |
Line 528: |
| |Acute megakaryoblastic leukaemia | | |Acute megakaryoblastic leukaemia |
| |Disease | | |Disease |
− | |Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR | + | | |
| | | | | |
| | | | | |
Line 536: |
Line 536: |
| | | | | |
| | | | | |
− | | | + | |Acute Megakaryoblastic Leukemia (AMKL) |
− | | | + | |Fei Yang, MD, FACMG <br> Oregon Health & Science University |
− | | | + | |Complete |
| | | | | |
| | | | | |
Line 544: |
Line 544: |
| |Myeloid sarcoma | | |Myeloid sarcoma |
| |Disease | | |Disease |
− | |Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | + | | |
| | | | | |
| | | | | |
Line 552: |
Line 552: |
| | | | | |
| | | | | |
− | | | + | |Myeloid Sarcoma |
− | | | + | |Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine |
− | | | + | |Complete |
| | | | | |
| | | | | |